<div id="readability-page-1"><div><p>Hologic, Inc. will be presented at the Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, Illinois. In a study led by Dr. Manisha Bahl, M.D., MPH, FSBI, Associate Medical Director of Quality at Mass General Brigham and Associate Professor of Radiology at Harvard Medical School, researchers at Massachusetts General Hospital evaluated Hologic's 3DQuorum imaging technology. Based on more than 160,000 screening mammography exams, the retrospective study compared cancer detection rates before and after adopting 3DQuorum imaging technology, which uses AI to reduce the number of 3D imaging &#34;slices&#34; radiologists need to review without compromising image quality, sensitivity or accuracy.</p><p>In the simplest terms, the technology is comparable to condensing a 60-page book into a 10-page summary that retains all relevant information and highlights key findings. The study found no significant difference in cancer detection rates after implementation of 3DQuorum. With ongoing radiologist shortages, these results suggest the technology's potential to streamline radiologists' workflows and save valuable time while maintaining high effectiveness in detecting cancers.</p><p>Another study, led by Professor Yan Chen, Ph.D., Chair of Digital Screening and Head of the Digital Cancer Screening Research Group at the University of Nottingham, U.K., looked at Hologic's Genius AI®? Detection solution compared with radiologists. In this study, 108radiologists from the U.K. and U.S. reviewed 75 challenging breast cancer cases, and the AI system assessed the same cases.</p><p>Overall, the AI technology performed similarly to radiologists. It detected more cancers but also showed lower specific, meaning it could flag more false positives. Although the study is still ongoing, these initial findings indicate that AI could help radiologists manage workloads in settings where double reading by multiple radiologists is required but staffing may be limited.</p><p>Hologic will also showcase its latest innovations at RSNA, including the AI-powered Genius AI Detection suite of products, leading breast surgery technologies and the next-generation Envision?? Mammography Platform with tilt positioning designed to adapt to patients. The company will host multiple medical education events throughout the congress, spanning the latest technologies in AI, contrast-enhanced mammography (CEM) and breast surgery.</p></div></div>

豪洛捷

<p>霍洛捷公司將在芝加哥的 RSNA 會議上展示其最新創新。由 Manisha Bahl 博士和 Yan Chen 教授領導的研究分別評估了霍洛捷的 3DQuorum 成像技術和 Genius AI 檢測解決方案。3DQuorum 技術在不影響癌症檢測率的情況下簡化了放射科醫生的工作流程，而 AI 解決方案的表現與放射科醫生相似，有助於工作負載管理。霍洛捷還將展示基於 AI 的產品、乳腺手術技術以及 Envision 乳腺攝影平台，並舉辦關於 AI、CEM 和乳腺手術的教育活動</p>

豪洛捷公司將在北美放射學會年會上展示其最新的創新技術